Skip to content

Advertisement

  • Poster presentation
  • Open Access

Developing easy access patient information booklets and consent forms for use in multicentre stroke trials

  • 1,
  • 1 and
  • 2
Trials201314 (Suppl 1) :P58

https://doi.org/10.1186/1745-6215-14-S1-P58

  • Published:

Keywords

  • Acute Stroke
  • Aphasia
  • Stroke Survivor
  • Information Provision
  • Accessible Format

Global cognitive impairment is a common consequence of stroke, and some stroke patients will have had dementia prior to their stroke. Thus, many people with acute stroke are often considered unable to consent to participation in research and proxy consent is standard. Aphasia is a common neurological consequence of stroke, affecting several aspects of language including speaking, writing, reading and understanding but not necessarily impacting on self determination. Ethically, patients with capacity to consent should be enabled to engage in the information provision and consent process rather than making an assumption of incapacity.

For our ongoing multicentre FOCUS trial (http://www.focustrial.org.uk), we developed ‘easy-access' patient information booklets and consent forms to facilitate information provision and informed consent with people with communication impairment.

Co-produced in an iterative process with stroke survivors with aphasia (Speakeasy, Dundee) the information provided in the standard forms was refined into a more accessible format. Short sentences, simple grammatical structures and large well spaced text was supplemented with photographs, where possible, to support the information provision process. Approved by Scotland A Research Ethics Committee, preliminary experience suggests the ‘easy-access' versions have supported patients with mild aphasia. Recording which version of the information booklets was used and the presence and severity of aphasia (National Institute of Health Stroke Scale) will enable us to report how many patients with aphasia were enabled to independently consent to participation in the FOCUS trial.

Authors’ Affiliations

(1)
University of Edinburgh, Edinburgh, UK
(2)
Glasgow Caledonian University, Glasgow, UK

Copyright

© Mead et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement